Unichem Laboratories Limited (NSE:UNICHEMLAB)
India
· Delayed Price · Currency is INR 647.55
+33.90 (5.52%)
Jun 11, 2025, 3:30 PM IST
Unichem Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 21,110 | 17,049 | 13,430 | 12,698 | 12,351 | Upgrade
|
Revenue Growth (YoY) | 23.82% | 26.95% | 5.76% | 2.81% | 11.91% | Upgrade
|
Cost of Revenue | 8,637 | 7,228 | 6,064 | 4,686 | 4,260 | Upgrade
|
Gross Profit | 12,473 | 9,821 | 7,366 | 8,013 | 8,091 | Upgrade
|
Selling, General & Admin | 4,022 | 4,100 | 3,690 | 3,468 | 3,113 | Upgrade
|
Other Operating Expenses | 5,802 | 4,719 | 4,098 | 3,742 | 4,062 | Upgrade
|
Operating Expenses | 11,070 | 9,951 | 8,922 | 8,122 | 8,018 | Upgrade
|
Operating Income | 1,403 | -129.93 | -1,556 | -109.01 | 72.76 | Upgrade
|
Interest Expense | -210.3 | -221.55 | -162.52 | -50.21 | -44 | Upgrade
|
Interest & Investment Income | - | 6.77 | 5.22 | 164.91 | 229.43 | Upgrade
|
Earnings From Equity Investments | - | - | - | -10.61 | -3.43 | Upgrade
|
Currency Exchange Gain (Loss) | - | 223.99 | 273.16 | 273.82 | 105.39 | Upgrade
|
Other Non Operating Income (Expenses) | 353.2 | -0.84 | -41.33 | -29.37 | 43.45 | Upgrade
|
EBT Excluding Unusual Items | 1,546 | -121.55 | -1,481 | 239.53 | 403.6 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 64.64 | 90.49 | -17.49 | 116.42 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 16.33 | 12.83 | -2.34 | -5.23 | Upgrade
|
Other Unusual Items | - | -576.08 | -385.66 | - | - | Upgrade
|
Pretax Income | 1,546 | -616.66 | -1,764 | 219.69 | 514.79 | Upgrade
|
Income Tax Expense | 170.7 | 88.08 | 258.65 | -110.93 | 171.55 | Upgrade
|
Earnings From Continuing Operations | 1,375 | -704.74 | -2,022 | 330.62 | 343.25 | Upgrade
|
Net Income | 1,375 | -704.74 | -2,022 | 330.62 | 343.25 | Upgrade
|
Net Income to Common | 1,375 | -704.74 | -2,022 | 330.62 | 343.25 | Upgrade
|
Net Income Growth | - | - | - | -3.68% | - | Upgrade
|
Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | Upgrade
|
Shares Outstanding (Diluted) | 71 | 70 | 70 | 71 | 70 | Upgrade
|
Shares Change (YoY) | 0.32% | - | -0.25% | 0.25% | 0.01% | Upgrade
|
EPS (Basic) | 19.53 | -10.01 | -28.72 | 4.70 | 4.88 | Upgrade
|
EPS (Diluted) | 19.47 | -10.01 | -28.72 | 4.68 | 4.88 | Upgrade
|
EPS Growth | - | - | - | -4.01% | - | Upgrade
|
Free Cash Flow | -1,444 | -58.53 | -1,294 | -3,866 | -2,548 | Upgrade
|
Free Cash Flow Per Share | -20.44 | -0.83 | -18.38 | -54.78 | -36.20 | Upgrade
|
Dividend Per Share | - | - | - | 4.000 | 4.000 | Upgrade
|
Gross Margin | 59.09% | 57.61% | 54.85% | 63.10% | 65.51% | Upgrade
|
Operating Margin | 6.65% | -0.76% | -11.58% | -0.86% | 0.59% | Upgrade
|
Profit Margin | 6.51% | -4.13% | -15.06% | 2.60% | 2.78% | Upgrade
|
Free Cash Flow Margin | -6.84% | -0.34% | -9.63% | -30.45% | -20.63% | Upgrade
|
EBITDA | 2,649 | 943.71 | -480.19 | 747.05 | 838.59 | Upgrade
|
EBITDA Margin | 12.55% | 5.54% | -3.57% | 5.88% | 6.79% | Upgrade
|
D&A For EBITDA | 1,246 | 1,074 | 1,076 | 856.06 | 765.83 | Upgrade
|
EBIT | 1,403 | -129.93 | -1,556 | -109.01 | 72.76 | Upgrade
|
EBIT Margin | 6.65% | -0.76% | -11.58% | -0.86% | 0.59% | Upgrade
|
Effective Tax Rate | 11.04% | - | - | - | 33.32% | Upgrade
|
Revenue as Reported | 21,463 | 17,365 | 13,815 | 13,173 | 12,853 | Upgrade
|
Advertising Expenses | - | 157.73 | 117.46 | 144.12 | 26.81 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.